Proptosis as the presenting sign of giant prolactinoma in a prepubertal boy: Successful resolution of hydrocephalus by use of medical therapy

Future Oncology

Volumn 8, Issue 12, 2012, Pages 1621-1626

  Cackett, Peter ^a   Eunson, Graeme ^b   Bath, Louise ^b   Mulvihill, Alan ^a  

^a Princess Alexandra Eye Pavilion ^*  (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

cabergoline; giant prolactinoma; hydrocephalus; hyperprolactinemia; hypopituitarism; proptosis; quinagolide

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DEXAMETHASONE; DOPAMINE RECEPTOR STIMULATING AGENT; HYDROCORTISONE; PERGOLIDE; QUINAGOLIDE; RECOMBINANT GROWTH HORMONE; TESTOSTERONE; THYROXINE;

ADOLESCENT; BRAIN EDEMA; CANCER INVASION; CASE REPORT; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG POTENTIATION; EXOPHTHALMOS; FIBROSIS; FOLLOW UP; GIANT PROLACTINOMA; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYDROCEPHALUS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLEDEMA; PREPUBERTY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; VALVULAR HEART DISEASE; VISUAL FIELD DEFECT;

ADOLESCENT; AMINOQUINOLINES; DOPAMINE AGONISTS; ERGOLINES; EXOPHTHALMOS; HUMANS; HYDROCEPHALUS; MALE; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA;

EID: 84871232522     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.149     Document Type: Review

References (19)

1. Wang MY, Weiss MH. Is there a role for surgery for microprolactinomas? Semin. Neurosurg. 12, 289-294 (2001
2. Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin. Endocrinol. 65, 265-273 (2006
3. Liu JK, Couldwell WT. Contemporary management of prolactinomas. Neurosurg. Focus 16(4), E2 (2004
4. Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. Endocrine Rev. 27(5), 485-534 (2006
5. Schlechte JA. Prolactinoma (Clinical Practice). N. Engl. J. Med. 349(21), 2035-2041 (2003
6. Levy A. Pituitary disease: Presentation, diagnosis, and management. J. Neurol. Neurosurg. Psychiatr. 75(SUPPL3), iii47-iii52 (2004
7. Berwaerts J, Verhelst J, Abs R, Appel B, Mahler C. A giant prolactinoma presenting with unilateral exophthalmos: Effect of cabergoline and review of the literature. J. Endocrinol. Invest. 23(6), 393-398 (2000
8. Krassas GE, Pontikides N, Kaltsas T. Giant prolactinoma presented as unilateral exophthalmos in a prepubertal boy: Response to cabergoline. Horm. Res. 52(1), 45-48 (1999
9. Ross RJ, McEniery JM, Grossman A, Doniach I, Besser GM, Savage MO. Massive prolactinoma with galactorrhoea in a prepubertal boy. Postgrad. Med. J. 65(764), 403-446 (1989
10. Perani D, Colombo N, Scotti G, Tonon C. Rapid size reduction of giant prolactinoma following medical treatment. J. Comput. Assist. Tomogr. 8, 131-133 (1984
11. Zikel OM, Atkinson JLD, Hurley DL. Prolactinoma manifesting with symptomatic hydrocephalus. Mayo Clin. Proc. 74, 475-477 (1999
12. Sarkar PK, Manapuzha R, Ahmad S, Ritch AE. Fluctuating confusional state due to massive macro-prolactinoma resulting in obstructive hydrocephalus. Age Ageing 30, 426-428 (2001
13. Iglesias P, Macho LP, Diez JJ. Resolution of macroprolactinoma-induced symptomatic hydrocephalus following cabergoline therapy. Age Ageing 33(4), 410-412 (2004
14. Še P, Losa M, Mortini P, Giovanelli M. Obstructive hydrocephalus and intracranial hypertension caused by a giant macroprolactinoma. Prompt response to medical treatment. J. Neurooncol. 76(1), 51-54 (2006
15. Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiac valve regurgitation. N. Engl. J. Med. 356, 29-38 (2007
16. Zanetti R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N. Engl. J. Med. 356, 39-46 (2007
17. Colao A, Annunziato L, Lombardi G. Treatment of prolactinomas. Ann. Med. 30, 452-459 (1998
18. Shrivastava RK, Arginteanu MS, King WA, Post KD. Giant prolactinomas: Clinical management and long-term follow up. J. Neurosurg. 97(2), 299-306 (2002
19. Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. Transsphenoidal microsurgical therapy of prolactinomas: Initial outcomes and long-term results. Neurosurgery 44, 254-263 (1999